Healthlink Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
Healthlink Capital specializes in healthcare, medical technology, and pharmaceuticals.
Investor Profile
Healthlink Capital has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Clinical Trials.
Stage Focus
- Series B (50%)
- Series A (50%)
Country Focus
- United States (75%)
- United Kingdom (25%)
Industry Focus
- Biotechnology
- Health Care
- Clinical Trials
- Pharmaceutical
- Medical
- Therapeutics
- Bioinformatics
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Healthlink Capital frequently co-invest with?
What are some of recent deals done by Healthlink Capital?
Find More Investors Like Healthlink Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









